CompoAtlas

HORMONE CONNECTION ADRENAL REBALANCE

Natural health product licensed in Canada

Licence holder
IHH Products Division Inc.
NPN or DIN-HM
80071105
Status
Inactive licence
Licence date
14 July 2016
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Withania somnifera

Source : Racine

Extraction ratio : 12:1

Dry plant equivalent : 1,008 milligramme

Potency : 1.5 % Withanolides

84 milligrammeNot calculated
Avena sativa

Source : Tige

Extraction ratio : 10:1

Dry plant equivalent : 2,500 milligramme

250 milligrammeNot calculated
Dioscorea villosa

Source : Racine

Extraction ratio : 10:1

Dry plant equivalent : 2,000 milligramme

Potency : 6 % Diosgenin

200 milligrammeNot calculated
Schisandra chinensis

Source : Fruit

Extraction ratio : 12:1

Dry plant equivalent : 1,200 milligramme

Potency : 1 % Schisandrins

100 milligrammeNot calculated
Rhodiola rosea

Source : Racine et rhizome

Extraction ratio : 6.944:1

Dry plant equivalent : 500 milligramme

Potency : 2 % Salidroside

72 milligrammeNot calculated
Lepidium meyenii

Source : Racine

Extraction ratio : 4:1

Dry plant equivalent : 1,740 milligramme

435 milligrammeNot calculated
Phosphatidylsérine

Source : Phosphatidylserine

50 milligrammeNot calculated
Magnésium

Source : Glycinate de magnésium

100 milligrammeNot calculated
L-Carnitine

Source : L-tartrate de carnitine

1,000 milligrammeNot calculated
Ribo-2,3,4,5-tétrahydroxyvaléraldéhyde, D-

Source : Ribose

3,170 milligrammeNot calculated
Cynorrhodon

Source : Rosa canina, Fruit

100 milligrammeNot calculated
Eleutherococcus senticosus

Source : Racine

Extraction ratio : 10:1

Dry plant equivalent : 1,000 milligramme

Potency : 0.8 % Eleutherosides

100 milligrammeNot calculated
Rhodiola rosea

Source : Racine et rhizome

Potency : 3 % Rosavins

Not specifiedNot calculated

Non-medicinal ingredients

Acide L-malique, Saveur de vanille, Feuille de Stevia rebaudiana, Saveur d'orange, Dioxyde de silicium, Arabinogalactane

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Portion(s)2 Tous les jours

Uses authorised in Canada

Helps temporally relieve symptoms of stress / Helps to support healthy mood balance during menopause / Helps delay fatigue during physical activity.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80071105

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Withania somnifera
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 February 2025

  • Lepidium meyenii
    Read the warning, when it applies and the studies cited

    Maca - Lepidium Meyenii

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Applies to products providing 0.6 g or more dried root/hypocotyl, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Healthy mood balance; Sexual health.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 27 September 2024

  • Phosphatidylsérine
    Read the warning, when it applies and the studies cited
  • L-Carnitine
    Read the warning, when it applies and the studies cited

    L-CARNITINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 25 July 2025

  • Eleutherococcus senticosus
    Read the warning, when it applies and the studies cited

    ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS

    Route of administration: Oral (ESCOP 2003; Bradley 1992)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 31 October 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line